{"id":46857,"date":"2023-12-21T17:14:58","date_gmt":"2023-12-21T15:14:58","guid":{"rendered":"https:\/\/www.ipsen.com\/?p=46857"},"modified":"2024-01-17T18:48:22","modified_gmt":"2024-01-17T16:48:22","slug":"j-p-morgan-2024-ipsen-presente-ses-progres-sa-prochaine-phase-de-croissance-et-ses-ambitions-en-matiere-de-partenariats","status":"publish","type":"post","link":"https:\/\/www.ipsen.com\/fr\/actualites\/partenariat\/j-p-morgan-2024-ipsen-presente-ses-progres-sa-prochaine-phase-de-croissance-et-ses-ambitions-en-matiere-de-partenariats\/","title":{"rendered":"J.P. Morgan 2024 : Ipsen pr\u00e9sente ses progr\u00e8s, sa prochaine phase de croissance et ses ambitions en mati\u00e8re de partenariats"},"content":{"rendered":"\n<p>Lors de la conf\u00e9rence J.P. Morgan Healthcare qui se tiendra \u00e0 San Francisco du 8 au 11 janvier 2024, <a>l&#8217;\u00e9quipe de direction d&#8217;Ipsen<\/a> discuterat de notre prochaine phase de croissance et de transformation ainsi que de nos ambitions en mati\u00e8re d&#8217;innovation externe.<\/p>\n\n\n\n<p><\/p>\n\n\n\n<p><strong>Une bonne dynamique de croissance<\/strong><\/p>\n\n\n\n<p><a>Au cours des trois derni\u00e8res ann\u00e9es, nous avons compl\u00e8tement transform\u00e9 l\u2019ensemble de nos m\u00e9dicaments et le portefeuille de produits en R&amp;D, conform\u00e9ment \u00e0 la feuille de route strat\u00e9gique \u00e9tablie \u00e0 la fin de l&#8217;ann\u00e9e 2020. Nous sommes maintenant pr\u00eats \u00e0 passer \u00e0 la phase suivante de notre transformation.<\/a><\/p>\n\n\n\n<p>En 2022, le chiffre d&#8217;affaires total d&#8217;Ipsen a d\u00e9pass\u00e9 les 3 milliards d&#8217;euros. Notre portefeuille inclut d\u00e9sormais quatre m\u00e9dicaments &#8211; Dysport, Cabometyx, Decapeptyl et Somatuline \u2013 qui devraient g\u00e9n\u00e9rer des pics de ventes d&#8217;au moins 500 millions d&#8217;euros chacun. A plus long terme, nous pr\u00e9voyons que sept m\u00e9dicaments de notre portefeuille pourraient atteindre ce potentiel, ce qui nous place en bonne position pour maintenir une solide croissance. <\/p>\n\n\n\n<p>Nous nous pr\u00e9parons maintenant \u00e0 poursuivre notre croissance sur la p\u00e9riode 2023-2027. En d\u00e9cembre 2023, Ipsen a pr\u00e9sent\u00e9 ses perspectives \u00e0 moyen terme lors de sa Journ\u00e9e Investisseurs \u2013 une croissance moyenne des ventes totales du Groupe d&#8217;au moins 7% par an pour la p\u00e9riode 2023-27 (\u00e0 taux de change constants) et une marge op\u00e9rationnelle des activit\u00e9s d&#8217;au moins 32% des ventes totales du Groupe en 2027. Ces perspectives excluent l&#8217;impact potentiel de transactions suppl\u00e9mentaires d\u2019innovation externe de produits en phase avanc\u00e9e.<\/p>\n\n\n\n<p>David Loew, Directeur G\u00e9n\u00e9ral, Aymeric Le Chatelier, Directeur Financier, Christelle Huguet, Directrice R&amp;D, et Philippe Lopes-Fernandes, Chief Business Officer, participent \u00e0 la conf\u00e9rence J.P. Morgan.<\/p>\n\n\n\n<p><\/p>\n\n\n\n<p><strong>Un argumentaire solide en faveur de l&#8217;investissement<\/strong><\/p>\n\n\n\n<p>Le 9 janvier, David Loew fera une pr\u00e9sentation sur les progr\u00e8s strat\u00e9giques d&#8217;Ipsen, les perspectives \u00e0 moyen terme et les opportunit\u00e9s de croissance. Son intervention sera suivie d&#8217;une s\u00e9ance de questions-r\u00e9ponses. Nous organisons \u00e9galement une s\u00e9rie de r\u00e9unions pour discuter de notre mod\u00e8le d\u2019affaires convaincant avec des investisseurs et des analystes. Si vous \u00eates un investisseur et que vous souhaitez rencontrer nos dirigeants et notre \u00e9quipe de relations investisseurs, n\u2019h\u00e9sitez pas \u00e0 contacter JP Morgan pour organiser une r\u00e9union.<\/p>\n\n\n\n<p><\/p>\n\n\n\n<p><strong>Des partenariats pour am\u00e9liorer la vie des patients<\/strong><\/p>\n\n\n    <section class=\"video-card \">\n        <div class=\"container\">\n            <!-- Block Details -->\n            <div class=\"video-card-header\">\n                <h3 class=\"video-card-block-title hidden heading-three\">\n                                    <\/h3>\n                <p class=\"charcoal-grey video-card-block-summary hidden\"> \n                                    <\/p>\n            <\/div>\n\n            <!-- Video Iframe embed -->\n                            <div class=\"video-embed\"> \n                <iframe loading=\"lazy\" title=\"Ipsen Our Partners Inspire Us\" src=\"https:\/\/player.vimeo.com\/video\/897515260?h=024349cf6e&amp;app_id=122963&#038;autoplay=1&#038;muted=1&#038;controls=1&#038;loop=1&#038;autopause=1&#038;background=0\" width=\"640\" height=\"360\" frameborder=\"0\" allow=\"autoplay; fullscreen; picture-in-picture; clipboard-write; encrypted-media; web-share\" referrerpolicy=\"strict-origin-when-cross-origin\" frameborder=\"0\" allow=\"autoplay; fullscreen; picture-in-picture\" data-ot-ignore><\/iframe>                <\/div>\n            \n            <!-- Block CTA -->\n            <div class=\"cta-block hidden\">\n                            <\/div>\n\n        <\/div>\n    <\/section>\n\n\n\n<p>Chez Ipsen, nous savons que les bons partenariats sont cr\u00e9ateurs d\u2019opportunit\u00e9s et permettent d&#8217;apporter plus rapidement des solutions th\u00e9rapeutiques aux patients. Ces derni\u00e8res ann\u00e9es, nous avons acquis deux soci\u00e9t\u00e9s de biotechnologies &#8212; Epizyme et Albireo &#8212; et sign\u00e9 des accords de licence qui ont aliment\u00e9 notre portefeuille de produits en R&amp;D avec 20+ programmes suppl\u00e9mentaires. A court terme, nous pr\u00e9voyons de franchir des importantes \u00e9tapes en mati\u00e8re de R&amp;D. Nous accentuons nos efforts en mati\u00e8re d&#8217;innovation externe afin de continuer \u00e0 alimenter notre portefeuille en R&amp;D \u00e0 travers toutes les phases de d\u00e9veloppement. Grace \u00e0 un bon flux de tr\u00e9sorerie disponible et une rentabilit\u00e9 \u00e9lev\u00e9e, notre capacit\u00e9 d\u2019investissement pour des acquisitions et des partenariats pourrait cumuler jusqu&#8217;\u00e0 5 milliards d&#8217;euros d&#8217;ici 2027.<\/p>\n\n\n\n<p>Philippe Lopes-Fernandes, Chief Business Officer, Christelle Huguet, Directrice R&amp;D, et <a href=\"https:\/\/www.ipsen.com\/wp-content\/uploads\/2023\/05\/Your-parterning-contacts.pdf\">leurs \u00e9quipes<\/a> se rendront \u00e0 San Francisco pour rencontrer des biotechs qui cherche un partenaire pour d\u00e9velopper leurs projets de recherche dans un des trois domaines th\u00e9rapeutiques d&#8217;Ipsen &#8211; l&#8217;Oncologie, les Maladies Rares et les Neurosciences. A cette occasion, les \u00e9quipes pr\u00e9senterons notre bilan sur comment nous avons valoris\u00e9 les programmes R&amp;D issus de nos partenariats d\u2019innovation externe.<\/p>\n\n\n\n<p>Philippe participera \u00e9galement au panel &lt;&lt; Removing Barriers : Healthcare Access and Equity for AI &gt;&gt; au Biotech Showcase le 9 janvier.<\/p>\n\n\n\n<p>Nous invitons les parties int\u00e9ress\u00e9es \u00e0 <strong><span style=\"text-decoration: underline;\"><a href=\"mailto:nicolas.bogler@ipsen.com?cc=craig.marks@ipsen.com&amp;subject=Request%20a%20meeting%20at%20JP%20Morgan\">nous contacter pour convenir d&#8217;une rencontre pr\u00e9alable<\/a><\/span><\/strong>.<\/p>\n\n\n\n<p>Pour plus d&#8217;informations sur Ipsen, veuillez consulter nos pages <a href=\"https:\/\/www.ipsen.com\/fr\/investisseurs\/\"><strong><span style=\"text-decoration: underline;\">Investisseurs<\/span><\/strong><\/a> et <strong><span style=\"text-decoration: underline;\"><a href=\"https:\/\/www.ipsen.com\/fr\/partenariat\/\">Partenariats<\/a>.<\/span><\/strong><\/p>\n\n\n\n<p><\/p>\n","protected":false},"excerpt":{"rendered":"<p>Lors de la conf\u00e9rence J.P. Morgan Healthcare qui se tiendra \u00e0 San Francisco du 8 au 11 janvier 2024, l&#8217;\u00e9quipe<\/p>\n","protected":false},"author":9,"featured_media":46849,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"_jetpack_memberships_contains_paid_content":false,"footnotes":""},"categories":[24933],"tags":[],"class_list":["post-46857","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-partenariat","entry"],"acf":[],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v26.8 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>J.P. Morgan 2024 : Ipsen pr\u00e9sente ses progr\u00e8s, sa prochaine phase de croissance et ses ambitions en mati\u00e8re de partenariats - Global<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.ipsen.com\/fr\/actualites\/partenariat\/j-p-morgan-2024-ipsen-presente-ses-progres-sa-prochaine-phase-de-croissance-et-ses-ambitions-en-matiere-de-partenariats\/\" \/>\n<meta property=\"og:locale\" content=\"fr_FR\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"J.P. Morgan 2024 : Ipsen pr\u00e9sente ses progr\u00e8s, sa prochaine phase de croissance et ses ambitions en mati\u00e8re de partenariats - Global\" \/>\n<meta property=\"og:description\" content=\"Lors de la conf\u00e9rence J.P. Morgan Healthcare qui se tiendra \u00e0 San Francisco du 8 au 11 janvier 2024, l&#8217;\u00e9quipe\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.ipsen.com\/fr\/actualites\/partenariat\/j-p-morgan-2024-ipsen-presente-ses-progres-sa-prochaine-phase-de-croissance-et-ses-ambitions-en-matiere-de-partenariats\/\" \/>\n<meta property=\"og:site_name\" content=\"Global\" \/>\n<meta property=\"article:published_time\" content=\"2023-12-21T15:14:58+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2024-01-17T16:48:22+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.ipsen.com\/wp-content\/uploads\/2023\/12\/20231221_Visual-JPMorgan_Ipsen-com_1082x620pix.jpg\" \/>\n\t<meta property=\"og:image:width\" content=\"1082\" \/>\n\t<meta property=\"og:image:height\" content=\"620\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"author\" content=\"konstantinoskampanos\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:creator\" content=\"@ipsengroup\" \/>\n<meta name=\"twitter:site\" content=\"@ipsengroup\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"konstantinoskampanos\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"3 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\/\/www.ipsen.com\/fr\/actualites\/partenariat\/j-p-morgan-2024-ipsen-presente-ses-progres-sa-prochaine-phase-de-croissance-et-ses-ambitions-en-matiere-de-partenariats\/#article\",\"isPartOf\":{\"@id\":\"https:\/\/www.ipsen.com\/fr\/actualites\/partenariat\/j-p-morgan-2024-ipsen-presente-ses-progres-sa-prochaine-phase-de-croissance-et-ses-ambitions-en-matiere-de-partenariats\/\"},\"author\":{\"name\":\"konstantinoskampanos\",\"@id\":\"https:\/\/www.ipsen.com\/fr\/#\/schema\/person\/caf513ba91f9535b6b2d8a79d95764c5\"},\"headline\":\"J.P. Morgan 2024 : Ipsen pr\u00e9sente ses progr\u00e8s, sa prochaine phase de croissance et ses ambitions en mati\u00e8re de partenariats\",\"datePublished\":\"2023-12-21T15:14:58+00:00\",\"dateModified\":\"2024-01-17T16:48:22+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\/\/www.ipsen.com\/fr\/actualites\/partenariat\/j-p-morgan-2024-ipsen-presente-ses-progres-sa-prochaine-phase-de-croissance-et-ses-ambitions-en-matiere-de-partenariats\/\"},\"wordCount\":697,\"publisher\":{\"@id\":\"https:\/\/www.ipsen.com\/fr\/#organization\"},\"image\":{\"@id\":\"https:\/\/www.ipsen.com\/fr\/actualites\/partenariat\/j-p-morgan-2024-ipsen-presente-ses-progres-sa-prochaine-phase-de-croissance-et-ses-ambitions-en-matiere-de-partenariats\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/www.ipsen.com\/wp-content\/uploads\/2023\/12\/20231221_Visual-JPMorgan_Ipsen-com_1082x620pix.jpg\",\"articleSection\":[\"Partenariat\"],\"inLanguage\":\"fr-FR\"},{\"@type\":\"WebPage\",\"@id\":\"https:\/\/www.ipsen.com\/fr\/actualites\/partenariat\/j-p-morgan-2024-ipsen-presente-ses-progres-sa-prochaine-phase-de-croissance-et-ses-ambitions-en-matiere-de-partenariats\/\",\"url\":\"https:\/\/www.ipsen.com\/fr\/actualites\/partenariat\/j-p-morgan-2024-ipsen-presente-ses-progres-sa-prochaine-phase-de-croissance-et-ses-ambitions-en-matiere-de-partenariats\/\",\"name\":\"J.P. Morgan 2024 : Ipsen pr\u00e9sente ses progr\u00e8s, sa prochaine phase de croissance et ses ambitions en mati\u00e8re de partenariats - Global\",\"isPartOf\":{\"@id\":\"https:\/\/www.ipsen.com\/fr\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\/\/www.ipsen.com\/fr\/actualites\/partenariat\/j-p-morgan-2024-ipsen-presente-ses-progres-sa-prochaine-phase-de-croissance-et-ses-ambitions-en-matiere-de-partenariats\/#primaryimage\"},\"image\":{\"@id\":\"https:\/\/www.ipsen.com\/fr\/actualites\/partenariat\/j-p-morgan-2024-ipsen-presente-ses-progres-sa-prochaine-phase-de-croissance-et-ses-ambitions-en-matiere-de-partenariats\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/www.ipsen.com\/wp-content\/uploads\/2023\/12\/20231221_Visual-JPMorgan_Ipsen-com_1082x620pix.jpg\",\"datePublished\":\"2023-12-21T15:14:58+00:00\",\"dateModified\":\"2024-01-17T16:48:22+00:00\",\"breadcrumb\":{\"@id\":\"https:\/\/www.ipsen.com\/fr\/actualites\/partenariat\/j-p-morgan-2024-ipsen-presente-ses-progres-sa-prochaine-phase-de-croissance-et-ses-ambitions-en-matiere-de-partenariats\/#breadcrumb\"},\"inLanguage\":\"fr-FR\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/www.ipsen.com\/fr\/actualites\/partenariat\/j-p-morgan-2024-ipsen-presente-ses-progres-sa-prochaine-phase-de-croissance-et-ses-ambitions-en-matiere-de-partenariats\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"fr-FR\",\"@id\":\"https:\/\/www.ipsen.com\/fr\/actualites\/partenariat\/j-p-morgan-2024-ipsen-presente-ses-progres-sa-prochaine-phase-de-croissance-et-ses-ambitions-en-matiere-de-partenariats\/#primaryimage\",\"url\":\"https:\/\/www.ipsen.com\/wp-content\/uploads\/2023\/12\/20231221_Visual-JPMorgan_Ipsen-com_1082x620pix.jpg\",\"contentUrl\":\"https:\/\/www.ipsen.com\/wp-content\/uploads\/2023\/12\/20231221_Visual-JPMorgan_Ipsen-com_1082x620pix.jpg\",\"width\":1082,\"height\":620},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/www.ipsen.com\/fr\/actualites\/partenariat\/j-p-morgan-2024-ipsen-presente-ses-progres-sa-prochaine-phase-de-croissance-et-ses-ambitions-en-matiere-de-partenariats\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/www.ipsen.com\/fr\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"J.P. Morgan 2024 : Ipsen pr\u00e9sente ses progr\u00e8s, sa prochaine phase de croissance et ses ambitions en mati\u00e8re de partenariats\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/www.ipsen.com\/fr\/#website\",\"url\":\"https:\/\/www.ipsen.com\/fr\/\",\"name\":\"Global\",\"description\":\"\",\"publisher\":{\"@id\":\"https:\/\/www.ipsen.com\/fr\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/www.ipsen.com\/fr\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"fr-FR\"},{\"@type\":\"Organization\",\"@id\":\"https:\/\/www.ipsen.com\/fr\/#organization\",\"name\":\"IPSEN\",\"url\":\"https:\/\/www.ipsen.com\/fr\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"fr-FR\",\"@id\":\"https:\/\/www.ipsen.com\/fr\/#\/schema\/logo\/image\/\",\"url\":\"https:\/\/www.ipsen.com\/wp-content\/uploads\/2023\/12\/Latest_Ipsen-logo_168x48.svg\",\"contentUrl\":\"https:\/\/www.ipsen.com\/wp-content\/uploads\/2023\/12\/Latest_Ipsen-logo_168x48.svg\",\"caption\":\"IPSEN\"},\"image\":{\"@id\":\"https:\/\/www.ipsen.com\/fr\/#\/schema\/logo\/image\/\"},\"sameAs\":[\"https:\/\/www.facebook.com\/Ipsengroup\",\"https:\/\/x.com\/ipsengroup\"]},{\"@type\":\"Person\",\"@id\":\"https:\/\/www.ipsen.com\/fr\/#\/schema\/person\/caf513ba91f9535b6b2d8a79d95764c5\",\"name\":\"konstantinoskampanos\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"fr-FR\",\"@id\":\"https:\/\/www.ipsen.com\/fr\/#\/schema\/person\/image\/\",\"url\":\"https:\/\/secure.gravatar.com\/avatar\/461d8aaa3dc000968b96f9df6ebfd0f045990cabf9f91de7f7dc4b9542e2adc8?s=96&d=mm&r=g\",\"contentUrl\":\"https:\/\/secure.gravatar.com\/avatar\/461d8aaa3dc000968b96f9df6ebfd0f045990cabf9f91de7f7dc4b9542e2adc8?s=96&d=mm&r=g\",\"caption\":\"konstantinoskampanos\"}}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"J.P. Morgan 2024 : Ipsen pr\u00e9sente ses progr\u00e8s, sa prochaine phase de croissance et ses ambitions en mati\u00e8re de partenariats - Global","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.ipsen.com\/fr\/actualites\/partenariat\/j-p-morgan-2024-ipsen-presente-ses-progres-sa-prochaine-phase-de-croissance-et-ses-ambitions-en-matiere-de-partenariats\/","og_locale":"fr_FR","og_type":"article","og_title":"J.P. Morgan 2024 : Ipsen pr\u00e9sente ses progr\u00e8s, sa prochaine phase de croissance et ses ambitions en mati\u00e8re de partenariats - Global","og_description":"Lors de la conf\u00e9rence J.P. Morgan Healthcare qui se tiendra \u00e0 San Francisco du 8 au 11 janvier 2024, l&#8217;\u00e9quipe","og_url":"https:\/\/www.ipsen.com\/fr\/actualites\/partenariat\/j-p-morgan-2024-ipsen-presente-ses-progres-sa-prochaine-phase-de-croissance-et-ses-ambitions-en-matiere-de-partenariats\/","og_site_name":"Global","article_published_time":"2023-12-21T15:14:58+00:00","article_modified_time":"2024-01-17T16:48:22+00:00","og_image":[{"width":1082,"height":620,"url":"https:\/\/www.ipsen.com\/wp-content\/uploads\/2023\/12\/20231221_Visual-JPMorgan_Ipsen-com_1082x620pix.jpg","type":"image\/jpeg"}],"author":"konstantinoskampanos","twitter_card":"summary_large_image","twitter_creator":"@ipsengroup","twitter_site":"@ipsengroup","twitter_misc":{"Written by":"konstantinoskampanos","Est. reading time":"3 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.ipsen.com\/fr\/actualites\/partenariat\/j-p-morgan-2024-ipsen-presente-ses-progres-sa-prochaine-phase-de-croissance-et-ses-ambitions-en-matiere-de-partenariats\/#article","isPartOf":{"@id":"https:\/\/www.ipsen.com\/fr\/actualites\/partenariat\/j-p-morgan-2024-ipsen-presente-ses-progres-sa-prochaine-phase-de-croissance-et-ses-ambitions-en-matiere-de-partenariats\/"},"author":{"name":"konstantinoskampanos","@id":"https:\/\/www.ipsen.com\/fr\/#\/schema\/person\/caf513ba91f9535b6b2d8a79d95764c5"},"headline":"J.P. Morgan 2024 : Ipsen pr\u00e9sente ses progr\u00e8s, sa prochaine phase de croissance et ses ambitions en mati\u00e8re de partenariats","datePublished":"2023-12-21T15:14:58+00:00","dateModified":"2024-01-17T16:48:22+00:00","mainEntityOfPage":{"@id":"https:\/\/www.ipsen.com\/fr\/actualites\/partenariat\/j-p-morgan-2024-ipsen-presente-ses-progres-sa-prochaine-phase-de-croissance-et-ses-ambitions-en-matiere-de-partenariats\/"},"wordCount":697,"publisher":{"@id":"https:\/\/www.ipsen.com\/fr\/#organization"},"image":{"@id":"https:\/\/www.ipsen.com\/fr\/actualites\/partenariat\/j-p-morgan-2024-ipsen-presente-ses-progres-sa-prochaine-phase-de-croissance-et-ses-ambitions-en-matiere-de-partenariats\/#primaryimage"},"thumbnailUrl":"https:\/\/www.ipsen.com\/wp-content\/uploads\/2023\/12\/20231221_Visual-JPMorgan_Ipsen-com_1082x620pix.jpg","articleSection":["Partenariat"],"inLanguage":"fr-FR"},{"@type":"WebPage","@id":"https:\/\/www.ipsen.com\/fr\/actualites\/partenariat\/j-p-morgan-2024-ipsen-presente-ses-progres-sa-prochaine-phase-de-croissance-et-ses-ambitions-en-matiere-de-partenariats\/","url":"https:\/\/www.ipsen.com\/fr\/actualites\/partenariat\/j-p-morgan-2024-ipsen-presente-ses-progres-sa-prochaine-phase-de-croissance-et-ses-ambitions-en-matiere-de-partenariats\/","name":"J.P. Morgan 2024 : Ipsen pr\u00e9sente ses progr\u00e8s, sa prochaine phase de croissance et ses ambitions en mati\u00e8re de partenariats - Global","isPartOf":{"@id":"https:\/\/www.ipsen.com\/fr\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.ipsen.com\/fr\/actualites\/partenariat\/j-p-morgan-2024-ipsen-presente-ses-progres-sa-prochaine-phase-de-croissance-et-ses-ambitions-en-matiere-de-partenariats\/#primaryimage"},"image":{"@id":"https:\/\/www.ipsen.com\/fr\/actualites\/partenariat\/j-p-morgan-2024-ipsen-presente-ses-progres-sa-prochaine-phase-de-croissance-et-ses-ambitions-en-matiere-de-partenariats\/#primaryimage"},"thumbnailUrl":"https:\/\/www.ipsen.com\/wp-content\/uploads\/2023\/12\/20231221_Visual-JPMorgan_Ipsen-com_1082x620pix.jpg","datePublished":"2023-12-21T15:14:58+00:00","dateModified":"2024-01-17T16:48:22+00:00","breadcrumb":{"@id":"https:\/\/www.ipsen.com\/fr\/actualites\/partenariat\/j-p-morgan-2024-ipsen-presente-ses-progres-sa-prochaine-phase-de-croissance-et-ses-ambitions-en-matiere-de-partenariats\/#breadcrumb"},"inLanguage":"fr-FR","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.ipsen.com\/fr\/actualites\/partenariat\/j-p-morgan-2024-ipsen-presente-ses-progres-sa-prochaine-phase-de-croissance-et-ses-ambitions-en-matiere-de-partenariats\/"]}]},{"@type":"ImageObject","inLanguage":"fr-FR","@id":"https:\/\/www.ipsen.com\/fr\/actualites\/partenariat\/j-p-morgan-2024-ipsen-presente-ses-progres-sa-prochaine-phase-de-croissance-et-ses-ambitions-en-matiere-de-partenariats\/#primaryimage","url":"https:\/\/www.ipsen.com\/wp-content\/uploads\/2023\/12\/20231221_Visual-JPMorgan_Ipsen-com_1082x620pix.jpg","contentUrl":"https:\/\/www.ipsen.com\/wp-content\/uploads\/2023\/12\/20231221_Visual-JPMorgan_Ipsen-com_1082x620pix.jpg","width":1082,"height":620},{"@type":"BreadcrumbList","@id":"https:\/\/www.ipsen.com\/fr\/actualites\/partenariat\/j-p-morgan-2024-ipsen-presente-ses-progres-sa-prochaine-phase-de-croissance-et-ses-ambitions-en-matiere-de-partenariats\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.ipsen.com\/fr\/"},{"@type":"ListItem","position":2,"name":"J.P. Morgan 2024 : Ipsen pr\u00e9sente ses progr\u00e8s, sa prochaine phase de croissance et ses ambitions en mati\u00e8re de partenariats"}]},{"@type":"WebSite","@id":"https:\/\/www.ipsen.com\/fr\/#website","url":"https:\/\/www.ipsen.com\/fr\/","name":"Global","description":"","publisher":{"@id":"https:\/\/www.ipsen.com\/fr\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.ipsen.com\/fr\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"fr-FR"},{"@type":"Organization","@id":"https:\/\/www.ipsen.com\/fr\/#organization","name":"IPSEN","url":"https:\/\/www.ipsen.com\/fr\/","logo":{"@type":"ImageObject","inLanguage":"fr-FR","@id":"https:\/\/www.ipsen.com\/fr\/#\/schema\/logo\/image\/","url":"https:\/\/www.ipsen.com\/wp-content\/uploads\/2023\/12\/Latest_Ipsen-logo_168x48.svg","contentUrl":"https:\/\/www.ipsen.com\/wp-content\/uploads\/2023\/12\/Latest_Ipsen-logo_168x48.svg","caption":"IPSEN"},"image":{"@id":"https:\/\/www.ipsen.com\/fr\/#\/schema\/logo\/image\/"},"sameAs":["https:\/\/www.facebook.com\/Ipsengroup","https:\/\/x.com\/ipsengroup"]},{"@type":"Person","@id":"https:\/\/www.ipsen.com\/fr\/#\/schema\/person\/caf513ba91f9535b6b2d8a79d95764c5","name":"konstantinoskampanos","image":{"@type":"ImageObject","inLanguage":"fr-FR","@id":"https:\/\/www.ipsen.com\/fr\/#\/schema\/person\/image\/","url":"https:\/\/secure.gravatar.com\/avatar\/461d8aaa3dc000968b96f9df6ebfd0f045990cabf9f91de7f7dc4b9542e2adc8?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/461d8aaa3dc000968b96f9df6ebfd0f045990cabf9f91de7f7dc4b9542e2adc8?s=96&d=mm&r=g","caption":"konstantinoskampanos"}}]}},"jetpack_featured_media_url":"https:\/\/www.ipsen.com\/wp-content\/uploads\/2023\/12\/20231221_Visual-JPMorgan_Ipsen-com_1082x620pix.jpg","jetpack_sharing_enabled":true,"_links":{"self":[{"href":"https:\/\/www.ipsen.com\/fr\/wp-json\/wp\/v2\/posts\/46857","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.ipsen.com\/fr\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.ipsen.com\/fr\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.ipsen.com\/fr\/wp-json\/wp\/v2\/users\/9"}],"replies":[{"embeddable":true,"href":"https:\/\/www.ipsen.com\/fr\/wp-json\/wp\/v2\/comments?post=46857"}],"version-history":[{"count":7,"href":"https:\/\/www.ipsen.com\/fr\/wp-json\/wp\/v2\/posts\/46857\/revisions"}],"predecessor-version":[{"id":47519,"href":"https:\/\/www.ipsen.com\/fr\/wp-json\/wp\/v2\/posts\/46857\/revisions\/47519"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.ipsen.com\/fr\/wp-json\/wp\/v2\/media\/46849"}],"wp:attachment":[{"href":"https:\/\/www.ipsen.com\/fr\/wp-json\/wp\/v2\/media?parent=46857"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.ipsen.com\/fr\/wp-json\/wp\/v2\/categories?post=46857"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.ipsen.com\/fr\/wp-json\/wp\/v2\/tags?post=46857"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}